HER2 type cancer

2023 ASCO Annual Meeting; #ASCO23
June 5, 2023
ASCO Staff

Reunión anual de la American Society of Clinical Oncology de 2023: Trastuzumab Deruxtecan trata eficazmente los tumores que expresan HER-2 y la terapia de células T CAR ayuda a ralentizar o detener el mieloma múltiple 

Spanish
ASCO.Staff

La Reunión Anual de la American Society of Clinical Oncology (Sociedad Estadounidense de Oncología Clínica) se llevará a cabo del 2 al 6 de junio. Los aspectos destacados de la investigación del día incluyen el uso de trastuzumab deruxtecán para tratar tumores positivos para HER2 (receptor 2 del factor de crecimiento epidérmico humano) y el uso de terapia de células T con CAR (receptor de antígeno quimérico) para ralentizar o detener el mieloma múltiple.

Read More >>

Breast Cancer, Male - Introduction

ON THIS PAGE: You will find some basic information about this disease and the parts of the body it may affect. This is the first page of Cancer.Net’s Guide to Male Breast Cancer. Use the menu to see other pages. Think of that menu as a roadmap for this entire guide.

Male breast cancer, also called breast cancer in men, is rare. It occurs much less often than breast cancer in women. But the diseases are similar in many ways.

Subscribe to RSS - HER2 type cancer